Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus. Efficacy and possible positive predictors: a systematic review
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44555601%3A13450%2F25%3A43899201" target="_blank" >RIV/44555601:13450/25:43899201 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/25:10499765
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S2772529425001304" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2772529425001304</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.bas.2025.104311" target="_blank" >10.1016/j.bas.2025.104311</a>
Alternative languages
Result language
angličtina
Original language name
Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus. Efficacy and possible positive predictors: a systematic review
Original language description
Introduction: Current best practice for the treatment of idiopathic normal pressure hydrocephalus (iNPH) involves ventriculoperitoneal shunt implantation, which is associated with several long-term complications. Throughout the last two decades endoscopic third ventriculostomy (ETV) has emerged as an alternate therapeutic modality. This modality promises a lower incidence of surgical and postoperative complications. This review focuses on patients with iNPH treated via ETV, compares the efficacy of ETV between individual studies and summarizes predictive measures of ETV success. Methods: The development of the protocol was guided by the Preferred Reporting Items for Systematic Review and MetaAnalysis Protocols 2015 statement. Relevant literature was selected using complex registers and in several bibliographical databases. A total of 17 original articles comparing the efficacy of ETV were selected for the review, 12 of which were used to analyze positive predictors of ETV therapy. Results: A total of 282 patients with iNPH underwent ETV, with an average efficacy 63.7 %. Positive predictors of ETV treatment were the presence of pathological outflow resistance (Rout) in the ventricular compartment during cerebrospinal fluid (CSF) dynamic tests, hyperdynamic CSF flow, functional stenosis of the Sylvian aqueduct and/or bowing of the third ventricle on magnetic resonance imaging (MRI). Further positive predictors included short duration of symptoms and a predominantly gait-centric clinical presentation. Conclusion: Endoscopic treatment of patients with iNPH remains controversial and shunt surgery remains the treatment of choice. The analyzed studies show that a subset of patients profit from ETV. Further studies with robust randomized cohorts comparing ETV to shunting are necessary.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Brain and Spine
ISSN
2772-5294
e-ISSN
—
Volume of the periodical
2025
Issue of the periodical within the volume
5
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
8
Pages from-to
1-8
UT code for WoS article
001533703900002
EID of the result in the Scopus database
—